drugset / Trial / NCT02003638
Assessment Of Vascular Health After Niacin Therapy (AVANT)
RandomizedParallel-groupDouble-blind
Summary
This study is looking to see if niacin will lessen atherosclerotic plaque inflammation and favorably affect circulating levels of endothelial progenitor cells and microparticles in people with atherosclerotic disease on chronic statin therapy.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niacin | Small molecule | 6000 mg | Oral |